BackHeidelberg Pharma AG Overview

Heidelberg Pharma AG Long Term Debt

Heidelberg Pharma AG's long-term debt is $160K.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$164121.00
↓ 99.55% YoYΔ $-36.36M vs prior year quarter

Peer trimmed avg / median

Loading

Heidelberg Pharma AG Long Term Debt History

Loading

Heidelberg Pharma AG vs. peers: Long Term Debt Comparison

Loading

Heidelberg Pharma AG Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Heidelberg Pharma AG (HPHA.DE) FAQ

Heidelberg Pharma AG's long-term debt stands at $160K as of August 2026. That compares with $37M in the prior-year period — down 99.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Heidelberg Pharma AG reported $160K in long-term debt versus $37M a year earlier — a 99.6% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $37M in the prior-year period — down 99.6% year over year. Sustained growth in long-term debt can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Heidelberg Pharma AG's long-term debt evolved across reporting periods, while the comparison chart places HPHA.DE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, long-term debt is commonly used to spot outliers. Heidelberg Pharma AG's reading of $160K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.